The Angle from T. Rowe Price

In this episode of “The Angle,” health care portfolio manager Sal Rais joins Jennifer Martin to explore how new ways of treating disease are improving human health, and how breakthrough drugs can potentially create value for biotech innovators. The conversation explores the innovations driving an acceleration in drug discovery, why there tends to be significant performance dispersion in the biotech industry, and Sal’s optimistic views on the regulatory environment in Washington, DC.